(2015) described the development of angiotensin IV analogs including Dihexa and their HGF/c-Met potentiation mechanism (PMID: 25455861) Expression of Concern: The landmark 2012 paper describing Dihexa's cognitive effects received an expression of concern from the journal (PMID: 34551989), citing data integrity issues including questioned Western blot images Retraction: A follow-up paper from the same research group was retracted (PMID: 40312093), further undermining the evidence base for Dihexa's reported effects No Human Studies: No clinical trials, pharmacokinetic studies, or safety assessments have been conducted in humans Limited Independent Replication: The core claims about Dihexa's cognitive-enhancing effects have not been independently replicated by groups outside the original laboratory The Evidence Gap: This comparison starkly illustrates the difference between a compound with decades of clinical validation (Cerebrolysin) and one with provocative preclinical data undermined by integrity concerns (Dihexa)
The free fatty acids released through this process are metabolized for energy through standard oxidative pathways, completely bypassing the neuroendocrine circuits that govern hunger sensations
Research tool GHK-Cu reconstitution math Calculator for research-use dilution math
Mist Ampoule: Purified Water, Butylene Glycol, Niacinamide, Propanediol, Hydroxyethyl Urea, Glycerin, Betaine, Trehalose, C12-14 Pareth-12, Caprylyl Glycol, Polyglyceryl-10 Laurate, Glutathione (1000ppm), Allantoin, Dipropylene Glycol, Fragrance, Caprylic/Capric Triglyceride, Ethylhexyl Glycerin, Adenosine, Phosphatidylcholine, Hydrogenated Lecithin, 1,2-Hexanediol, Disodium Idithio A, Phytosteryl/Octyldodecyllauroyl Glutamate, Eucalyptus Leaf Extract, Perilla Leaf Extract, Ceramide NP, Sodium Hyaluronate, Ascorbic Acid, Tocopherol
